G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
54.70
-0.20 (-0.36%)
Apr 2, 2025, 1:13 PM CST
G&E Herbal Biotechnology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 152.59 | 139.68 | 114.75 | 12.28 | 14.46 | Upgrade
|
Short-Term Investments | 256.29 | 173.24 | 91.2 | 96.6 | 105.6 | Upgrade
|
Cash & Short-Term Investments | 408.87 | 312.92 | 205.95 | 108.88 | 120.06 | Upgrade
|
Cash Growth | 30.66% | 51.94% | 89.15% | -9.31% | -4.76% | Upgrade
|
Accounts Receivable | 17.8 | 14.78 | 0.75 | 5.09 | 6.09 | Upgrade
|
Other Receivables | 0.16 | 0.15 | 0.02 | 0.03 | 0.04 | Upgrade
|
Receivables | 17.96 | 14.93 | 0.77 | 5.12 | 6.13 | Upgrade
|
Inventory | 21.71 | 22.9 | 24.64 | 19.83 | 16.98 | Upgrade
|
Prepaid Expenses | 2.38 | 1.41 | 1.32 | 2.07 | 2.97 | Upgrade
|
Total Current Assets | 450.92 | 352.17 | 232.69 | 135.9 | 146.14 | Upgrade
|
Property, Plant & Equipment | 372.31 | 375.12 | 375.15 | 382.85 | 389.74 | Upgrade
|
Other Intangible Assets | 133.33 | 133.89 | 134.68 | 135.51 | 136.11 | Upgrade
|
Long-Term Deferred Tax Assets | 0.26 | 19.65 | 37.95 | 37.59 | 39.26 | Upgrade
|
Other Long-Term Assets | 2.37 | 2.27 | 2.31 | 0.28 | 0.48 | Upgrade
|
Total Assets | 959.17 | 883.1 | 782.78 | 692.13 | 711.73 | Upgrade
|
Accounts Payable | 8.34 | 4.03 | 8.97 | 2.73 | 3.16 | Upgrade
|
Accrued Expenses | 17.72 | 17.34 | 8.11 | 1.64 | 1.56 | Upgrade
|
Current Portion of Leases | 0.88 | 0.69 | - | - | - | Upgrade
|
Current Income Taxes Payable | 3.1 | - | - | - | - | Upgrade
|
Current Unearned Revenue | 85.23 | 95.24 | 71.85 | 0.45 | 0.17 | Upgrade
|
Other Current Liabilities | 9.51 | 1.28 | 2.82 | 3.85 | 3.5 | Upgrade
|
Total Current Liabilities | 124.77 | 118.57 | 91.74 | 8.68 | 8.39 | Upgrade
|
Long-Term Leases | 0.87 | 1.29 | - | - | - | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | 0.2 | - | - | Upgrade
|
Total Liabilities | 125.64 | 119.86 | 91.94 | 8.68 | 8.39 | Upgrade
|
Common Stock | 590 | 556.6 | 556.6 | 556.6 | 556.6 | Upgrade
|
Additional Paid-In Capital | 134.24 | 134.24 | 273.33 | 273.33 | 273.33 | Upgrade
|
Retained Earnings | 109.3 | 72.4 | -139.09 | -146.47 | -126.59 | Upgrade
|
Shareholders' Equity | 833.53 | 763.24 | 690.84 | 683.45 | 703.34 | Upgrade
|
Total Liabilities & Equity | 959.17 | 883.1 | 782.78 | 692.13 | 711.73 | Upgrade
|
Total Debt | 1.75 | 1.98 | - | - | - | Upgrade
|
Net Cash (Debt) | 407.13 | 310.94 | 205.95 | 108.88 | 120.06 | Upgrade
|
Net Cash Growth | 30.93% | 50.98% | 89.15% | -9.31% | -4.76% | Upgrade
|
Net Cash Per Share | 6.89 | 5.27 | 3.49 | 1.85 | 2.03 | Upgrade
|
Filing Date Shares Outstanding | 59 | 59 | 59 | 59 | 59 | Upgrade
|
Total Common Shares Outstanding | 59 | 59 | 59 | 59 | 59 | Upgrade
|
Working Capital | 326.14 | 233.6 | 140.95 | 127.22 | 137.75 | Upgrade
|
Book Value Per Share | 14.13 | 12.94 | 11.71 | 11.58 | 11.92 | Upgrade
|
Tangible Book Value | 700.21 | 629.34 | 556.16 | 547.95 | 567.23 | Upgrade
|
Tangible Book Value Per Share | 11.87 | 10.67 | 9.43 | 9.29 | 9.61 | Upgrade
|
Land | 148.59 | 148.59 | 148.59 | 148.59 | 148.59 | Upgrade
|
Buildings | 233.58 | 233.58 | 233.08 | 233.39 | 233.31 | Upgrade
|
Machinery | 50.77 | 52.08 | 55.06 | 55.32 | 57.12 | Upgrade
|
Construction In Progress | 2.39 | - | - | - | - | Upgrade
|
Leasehold Improvements | 5.33 | 5.33 | 5.33 | 5.33 | 5.33 | Upgrade
|
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.